scholarly article | Q13442814 |
P50 | author | Aleksander S. Popel | Q1642695 |
Kerri-Ann Norton | Q61103073 | ||
P2860 | cites work | Hallmarks of Cancer: The Next Generation | Q22252312 |
The epithelial-mesenchymal transition generates cells with properties of stem cells | Q24650786 | ||
Tumor self-seeding by circulating cancer cells | Q24658224 | ||
Modeling evolutionary dynamics of epigenetic mutations in hierarchically organized tumors | Q27333860 | ||
Identification of selective inhibitors of cancer stem cells by high-throughput screening | Q28255115 | ||
Identification of pancreatic cancer stem cells | Q28286997 | ||
A simple mathematical model based on the cancer stem cell hypothesis suggests kinetic commonalities in solid tumor growth | Q28480928 | ||
Microenvironmental regulation of metastasis | Q29547660 | ||
Metastasis: from dissemination to organ-specific colonization | Q29614295 | ||
Generation of breast cancer stem cells through epithelial-mesenchymal transition | Q29619717 | ||
Multiscale models of angiogenesis | Q30432668 | ||
Review article: the role of the perioperative period in recurrence after cancer surgery | Q30450754 | ||
Elongation, proliferation & migration differentiate endothelial cell phenotypes and determine capillary sprouting | Q30487167 | ||
Visualizing extravasation dynamics of metastatic tumor cells | Q30494902 | ||
Collective invasion in breast cancer requires a conserved basal epithelial program | Q30573307 | ||
Response to stress in early tumor colonization modulates switching of CD133-positive and CD133-negative subpopulations in a human metastatic colon cancer cell line, SW620 | Q31115121 | ||
A 2D mechanistic model of breast ductal carcinoma in situ (DCIS) morphology and progression | Q33729710 | ||
Determination of somatic and cancer stem cell self-renewing symmetric division rate using sphere assays | Q33796722 | ||
Tumor morphological evolution: directed migration and gain and loss of the self-metastatic phenotype | Q33846507 | ||
Dickkopf1 regulates fate decision and drives breast cancer stem cells to differentiation: an experimentally supported mathematical model | Q34018958 | ||
A multicompartment mathematical model of cancer stem cell-driven tumor growth dynamics | Q34076143 | ||
Oxygen levels do not determine radiation survival of breast cancer stem cells | Q34222667 | ||
Interactions between cancer stem cells and their niche govern metastatic colonization | Q34239769 | ||
The essence of senescence | Q34288983 | ||
Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas | Q34291885 | ||
Cancer stem cells: an old idea--a paradigm shift | Q34495973 | ||
Spatial pattern dynamics of 3D stem cell loss of pluripotency via rules-based computational modeling | Q34629083 | ||
The tumor growth paradox and immune system-mediated selection for cancer stem cells | Q43585250 | ||
Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. | Q45976160 | ||
Breast cancer stem cells: we've got them surrounded | Q46260559 | ||
Predicting the course of Gompertzian growth | Q46802559 | ||
Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation | Q47987665 | ||
Biphasic modulation of cancer stem cell-driven solid tumour dynamics in response to reactivated replicative senescence. | Q51099743 | ||
Strategies for cancer stem cell elimination: insights from mathematical modeling. | Q51459347 | ||
Investigating the link between epithelial-mesenchymal transition and the cancer stem cell phenotype: A mathematical approach. | Q51677689 | ||
Cancer stem cell tumor model reveals invasive morphology and increased phenotypical heterogeneity. | Q51760052 | ||
Integrative mathematical oncology. | Q51893016 | ||
A mathematical model of breast cancer development, local treatment and recurrence. | Q51922673 | ||
Conceptual and practical implications of breast tissue geometry: toward a more effective, less toxic therapy. | Q51971122 | ||
A Gompertzian model of human breast cancer growth. | Q52546950 | ||
Exploring cancer stem cell niche directed tumor growth. | Q53331008 | ||
Cancer stem cells, self-seeding, and decremented exponential growth: theoretical and clinical implications. | Q53436619 | ||
Is cancer a disease of self-seeding? | Q57578467 | ||
Growth rates of normal and abnormal human mammary epithelia in cell culture | Q67784851 | ||
Kinetics of mammary tumor cell growth and implications for therapy | Q70622373 | ||
Tumor self-seeding: bidirectional flow of tumor cells | Q82461407 | ||
Pulmonary vascular destabilization in the premetastatic phase facilitates lung metastasis | Q84579981 | ||
Paradoxical dependencies of tumor dormancy and progression on basic cell kinetics | Q84842492 | ||
Transcription factors associated with epithelial-mesenchymal transition and cancer stem cells in the tumor centre and margin of invasive breast cancer | Q84981793 | ||
Hybrid models of tumor growth. | Q34676158 | ||
Predicting clonal self-renewal and extinction of hematopoietic stem cells | Q34693735 | ||
The seed and soil hypothesis revisited--the role of tumor-stroma interactions in metastasis to different organs | Q34784896 | ||
Histologic classification of ductal carcinoma in situ | Q34954853 | ||
Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks | Q35001086 | ||
Isolation, immortalization, and characterization of a human breast epithelial cell line with stem cell properties | Q35005843 | ||
The role of breast cancer stem cells in metastasis and therapeutic implications | Q35070157 | ||
The small intestine as a model for evaluating adult tissue stem cell drug targets | Q35157532 | ||
Evolutionary dynamics of feedback escape and the development of stem-cell-driven cancers | Q35571371 | ||
Breast cancer stem cells, cytokine networks, and the tumor microenvironment | Q35571904 | ||
Modelling glandular epithelial cancers in three-dimensional cultures | Q36251934 | ||
Predictive oncology: a review of multidisciplinary, multiscale in silico modeling linking phenotype, morphology and growth | Q36464556 | ||
Selection of mammalian cells based on their cell-cycle phase using dielectrophoresis | Q36696301 | ||
Integrative physical oncology | Q36754194 | ||
Cancer Stem Cells: A Minor Cancer Subpopulation that Redefines Global Cancer Features. | Q36763883 | ||
A mathematical model of tumour self-seeding reveals secondary metastatic deposits as drivers of primary tumour growth. | Q36767922 | ||
Cellular quiescence in mammary stem cells and breast tumor stem cells: got testable hypotheses? | Q37077418 | ||
Mathematical models of cancer stem cells | Q37186435 | ||
Migration rules: tumours are conglomerates of self-metastases. | Q37271138 | ||
Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients | Q37360176 | ||
Multiscale models of breast cancer progression | Q37404422 | ||
Cancer stemness and metastasis: therapeutic consequences and perspectives | Q37715152 | ||
Targeting Wnt signaling: can we safely eradicate cancer stem cells? | Q37763415 | ||
Drug delivery strategies for therapeutic angiogenesis and antiangiogenesis | Q37845396 | ||
Clinical implications of cancer self-seeding | Q37869333 | ||
Cancer stem cells and angiogenesis | Q37898062 | ||
Cancer stem cells: distinct entities or dynamically regulated phenotypes? | Q37980717 | ||
Cancer stem cells: current status and evolving complexities | Q38019174 | ||
Cross talk between the Notch signaling and noncoding RNA on the fate of stem cells. | Q38037180 | ||
Tumor cell proliferation kinetics and tumor growth rate | Q38617591 | ||
Stem cell control, oscillations, and tissue regeneration in spatial and non-spatial models. | Q39834294 | ||
Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. | Q39997734 | ||
Defining the mode of tumour growth by clonal analysis | Q41356812 | ||
On the growth rates of human malignant tumors: implications for medical decision making | Q41579674 | ||
Integration of angiogenesis modules at multiple scales: from molecular to tissue | Q41876373 | ||
Targeting cancer stem cells via dendritic-cell vaccination | Q42067222 | ||
Migratory gene expression signature predicts poor patient outcome: are cancer stem cells to blame? | Q42670047 | ||
Stochastic dynamics of cancer initiation | Q43235502 | ||
Pathways to tumorigenesis--modeling mutation acquisition in stem cells and their progeny | Q43250252 | ||
P433 | issue | 100 | |
P921 | main subject | agent-based model | Q392811 |
neoplastic stem cells | Q1638475 | ||
P304 | page(s) | 20140640 | |
P577 | publication date | 2014-11-01 | |
P1433 | published in | Journal of the Royal Society Interface | Q2492390 |
P1476 | title | An agent-based model of cancer stem cell initiated avascular tumour growth and metastasis: the effect of seeding frequency and location | |
P478 | volume | 11 |
Q41809604 | A Computational Model of Cellular Engraftment on Lung Scaffolds |
Q42150466 | A computational multiscale agent-based model for simulating spatio-temporal tumour immune response to PD1 and PDL1 inhibition |
Q38667417 | A confidence building exercise in data and identifiability: Modeling cancer chemotherapy as a case study |
Q33873659 | ATP-P2Y2-β-catenin axis promotes cell invasion in breast cancer cells |
Q38780807 | Agent-Based Modeling of Cancer Stem Cell Driven Solid Tumor Growth |
Q38685879 | An agent-based model of triple-negative breast cancer: the interplay between chemokine receptor CCR5 expression, cancer stem cells, and hypoxia |
Q39449612 | Breast cancer neoplastic seeding in the setting of image-guided needle biopsies of the breast. |
Q88641629 | Modeling triple-negative breast cancer heterogeneity: Effects of stromal macrophages, fibroblasts and tumor vasculature |
Q57162853 | Novel roles of apoptotic caspases in tumor repopulation, epigenetic reprogramming, carcinogenesis, and beyond |
Q94563647 | The double-edged sword role of fibroblasts in the interaction with cancer cells; an agent-based modeling approach |
Q47237374 | Therapeutic potential of an anti-angiogenic multimodal biomimetic peptide in hepatocellular carcinoma. |
Search more.